MetMAb, a new compound under investigation, extends the time people with lung cancer live without their disease getting worse

Recent stories

Most people told to get a colonoscopy don't
>> Find out more

Ten biomarkers for lung cancer detection
>> Find out more

Diesel exhaust linked to lung cancer deaths
>> Find out more

Identify depressive symptoms early in breast cancer patients
>> Find out more

Antibiotics may help gastric DLBCL patients avoid chemo
>> Find out more

Risk of fatal adverse events in VEGF-targeting cancer drugs
>> Find out more

Vitamin E supplements linked to prostate cancer risk
>> Find out more

Aspirin: cancer prevention benefits outweigh risks for 55-75 age group
>> Find out more

How does prenatal chemotherapy exposure affect children?
>> Find out more

Colonoscopy with adenoma removal cut colorectal cancer deaths by 53%
>> Find out more

Faecal immunochemical test not good at finding adenomas
>> Find out more

Less intensive monitoring does not jeopardise melanoma care
>> Find out more

MDV3100 cuts risk of death in advanced prostate cancer
>> Find out more

We should no longer think of NSCLC as a single disease
>> Find out more

Arthritis drugs do not increase cancer risk, study suggests
>> Find out more

Link between ADT and cardiovascular death not found
>> Find out more

Vitamin D/breast cancer link questioned
>> Find out more

Acupuncture proves ineffective as pain relief
>> Find out more

Is personalised medicine the future for pancreatic cancer treatment?
>> Find out more

Left-sided radiotherapy linked to cardiovascular stenosis
>> Find out more